The 11 most recent market catalysts affecting $CLVT, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 24, 2026
Corporate Catalyst
Neutral
Impact 55
Clarivate Announces $665.198M Senior Notes Due 2028 Were Tendered Out Of $825M Outstanding In Cash Tender Offer Of Up To $75M
Clarivate successfully completed a cash tender offer for its 3.875% Senior Secured Notes due 2028. While a significant amount ($665.198 million) was tendered by bondholders, the co…
Sep 17, 2026
Corporate Catalyst
Neutral
Impact 65
Clarivate's Clarivate Science Holdings Announces Cash Tender Offer For Up To $75M Of Its 3.875% Senior Secured Notes Due 2028, Of $825M Outstanding; Offer Expires September 23, Settlement Expected September 25
This tender offer by Clarivate is a corporate catalyst, specifically a debt management action. By repurchasing a portion of its 3.875% Senior Secured Notes due 2028, Clarivate aims…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 65
Clarivate Expands Agentic AI Across Cortellis Portfolio To Accelerate Drug Development Decisions
This headline signals Clarivate's commitment to leveraging advanced AI to improve its core offerings, specifically in drug development decision-making. The integration of Agentic A…
Jul 30, 2026
Corporate Catalyst
Bearish
Impact 55
Citigroup Maintains Neutral on Clarivate, Lowers Price Target to $2.5
Citigroup analyst Peter Christiansen maintained a 'Neutral' rating on Clarivate but lowered the price target from $2.8 to $2.5. This action indicates a slightly diminished valuatio…
Jul 30, 2026
Corporate Catalyst
Bearish
Impact 55
Goldman Sachs Maintains Neutral on Clarivate, Lowers Price Target to $2.6
Goldman Sachs analyst George Tong maintained a 'Neutral' rating on Clarivate (CLVT) but lowered the price target from $2.9 to $2.6. This action indicates a slightly reduced valuati…
Jul 30, 2026
Corporate Catalyst
Bearish
Impact 55
Barclays Maintains Underweight on Clarivate, Lowers Price Target to $2
Barclays analyst Manav Patnaik maintained an 'Underweight' rating on Clarivate (CLVT) and lowered the price target from $2.50 to $2. This action signals a continued lack of confide…
Jul 29, 2026
Corporate Catalyst
Bearish
Impact 85
Clarivate shares are trading lower after the company reported worse-than-expected Q2 sales results. Also, the company lowered its FY2026 GAAP EPS guidance below estimates.
This headline represents a significant corporate catalyst for Clarivate (CLVT), directly impacting its stock price negatively. The combination of a Q2 sales miss and a reduction in…
Jul 29, 2026
Corporate Catalyst
Bearish
Impact 75
Clarivate Lowers FY2026 GAAP EPS Guidance from $(0.29)-$(0.19) to $(0.64)-$(0.54) vs $(0.17) Est
Clarivate (CLVT) has announced a substantial reduction in its GAAP EPS guidance for fiscal year 2026, moving from a range of $(0.29)-$(0.19) to a significantly lower range of $(0.6…
Jul 29, 2026
Corporate Catalyst
Neutral
Impact 75
Clarivate Appoints Michael Easton As EVP And CFO, Effective August 8, Succeeding Jonathan Collins
Clarivate Plc is replacing its Chief Financial Officer, a critical executive position responsible for the company's financial strategy and reporting. Jonathan Collins is stepping d…
Jul 29, 2026
Corporate Catalyst
Neutral
Impact 55
Clarivate Affirms FY2026 Adj EPS Guidance of $0.70-$0.80 vs $0.73 Est; Affirms FY2026 Sales Guidance of $2.300B-$2.420B vs $2.347B Est
Clarivate (CLVT) filed an 8-K to affirm its previously issued financial guidance for fiscal year 2026. This means the company is not changing its adjusted EPS outlook of $0.70-$0.8…
Jul 29, 2026
Corporate Catalyst
Neutral
Impact 65
Clarivate Q2 Adj. EPS $0.19 Beats $0.18 Estimate, Sales $587.300M Miss $589.729M Estimate
The headline indicates a moderate corporate catalyst for Clarivate (CLVT). While the adjusted EPS beat suggests effective cost management or higher-than-expected profitability on e…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.